Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia.
Jabbour E, Zugmaier G, Agrawal V, Martínez-Sánchez P, Rifón Roca JJ, Cassaday RD, Böll B, Rijneveld A, Abdul-Hay M, Huguet F, Cluzeau T, Díaz MT, Vucinic V, González-Campos J, Rambaldi A, Schwartz S, Berthon C, Hernández-Rivas JM, Gordon PR, Brüggemann M, Hamidi A, Chen Y, Wong HL, Panwar B, Katlinskaya Y, Markovic A, Kantarjian H. Jabbour E, et al. Among authors: zugmaier g. Am J Hematol. 2024 Apr;99(4):586-595. doi: 10.1002/ajh.27227. Epub 2024 Feb 5. Am J Hematol. 2024. PMID: 38317420
Blinatumomab is associated with better post-transplant outcome than chemotherapy in children with high-risk first-relapse B-cell acute lymphoblastic leukemia irrespective of the conditioning regimen.
Peters C, Bruno A, Rizzari C, Brescianini A, Von Stackelberg A, Linderkamp C, Zeng Y, Zugmaier G, Locatelli F. Peters C, et al. Among authors: zugmaier g. Haematologica. 2024 Sep 5. doi: 10.3324/haematol.2024.285837. Online ahead of print. Haematologica. 2024. PMID: 39234873 Free article.
Outcomes of children and young adults with B-cell acute lymphoblastic leukemia given blinatumomab as last consolidation treatment before allogeneic hematopoietic stem cell transplantation.
Algeri M, Massa M, Pagliara D, Bertaina V, Galaverna F, Pili I, Li Pira G, Carta R, Quagliarella F, Pinto RM, Rosignoli C, Lucarelli B, Cefalo MG, Boccieri E, Benini F, Del Bufalo F, Becilli M, Merli P, Zugmaier G, Locatelli F. Algeri M, et al. Among authors: zugmaier g. Haematologica. 2024 Oct 31. doi: 10.3324/haematol.2024.286350. Online ahead of print. Haematologica. 2024. PMID: 39479863 Free article.
Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse.
Hogan LE, Brown PA, Ji L, Xu X, Devidas M, Bhatla T, Borowitz MJ, Raetz EA, Carroll A, Heerema NA, Zugmaier G, Sharon E, Bernhardt MB, Terezakis SA, Gore L, Whitlock JA, Hunger SP, Loh ML. Hogan LE, et al. Among authors: zugmaier g. J Clin Oncol. 2023 Sep 1;41(25):4118-4129. doi: 10.1200/JCO.22.02200. Epub 2023 May 31. J Clin Oncol. 2023. PMID: 37257143 Free PMC article. Clinical Trial.
Application of blinatumomab, a bispecific anti-CD3/CD19 T-cell engager, in treating severe systemic sclerosis: A case study.
Subklewe M, Magno G, Gebhardt C, Bücklein V, Szelinski F, Arévalo HJR, Hänel G, Dörner T, Zugmaier G, von Bergwelt-Baildon M, Skapenko A, Schulze-Koops H. Subklewe M, et al. Among authors: zugmaier g. Eur J Cancer. 2024 Jun;204:114071. doi: 10.1016/j.ejca.2024.114071. Epub 2024 Apr 22. Eur J Cancer. 2024. PMID: 38691878 Free article.
Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study.
Boissel N, Chiaretti S, Papayannidis C, Ribera JM, Bassan R, Sokolov AN, Alam N, Brescianini A, Pezzani I, Kreuzbauer G, Zugmaier G, Foà R, Rambaldi A. Boissel N, et al. Among authors: zugmaier g. Blood Cancer J. 2023 Jan 4;13(1):2. doi: 10.1038/s41408-022-00766-7. Blood Cancer J. 2023. PMID: 36599847 Free PMC article.
110 results